| Sign In to gain access to subscriptions and/or personal tools. |
The use of thalidomide in the management of bleeding from a gastric cancer
1 Mid Yorkshire Hospitals NHS Trust, Dewsbury and District Hospital, Dewsbury
* To whom correspondence should be addressed.
Medical management of severe gastrointestinal bleeding can present a therapeutic challenge. We describe a case of bleeding secondary to gastric cancer that failed to settle, despite treatment with tranexamic acid, etamsylate and sucralfate. Thalidomide was prescribed for its antiangiogenic properties. Bleeding settled within 1 week of starting 300 mg of thalidomide nocte. The effect appeared to be dose dependant, with bleeding recurring only when the dose was reduced to 100 mg of thalidomide nocte. Key Words: cancer, gastrointestinal bleeding, thalidomide
First published on March 20, 2009, doi:10.1177/0269216309102526 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||